BryanL.E., BedardJ., WongS., ChamberlandS.Quinolone antimicrobial agents: Mechanism of action and resistance development.Clin Invest Med1989; 12: 14–19.
2.
PhillipsI., KingA.Comparative activity of the 4 quinolones.Rev Infect Dis1988; 10: 870–6.
3.
SmithJ.T.The mode of action of the quinolone antibac terials.Infection1986; 14(Suppl 1): 3–15.
4.
McCormickE.M., EcholsR.M.Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin.Antimicrob Agents Chemother1987; 31: 657–9.
NikolaidisP.Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis -related infections.Perit Dial Int1990; 10: 127–33.
7.
GolperT.A., HartsteinA.I., MorthlandV.H., ChristensenM.J.Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.AntimicrobAgents Chemother1987; 31: 1787–90.
8.
ShalitI., Kitzes-CohenR., RapaportJ., SchalaefferF., ChaimovitzC.Pharmacokinetics of ciprofloxacin in patients receiving peritoneal dialysis and being treated for peritonitis.Rev Infect Dis1989; 11(Suppl 5): 81072–3.
9.
DharmasenaD., RobertsD.E., ColesG.A., WilliamsJ.D.Pharmacokinetics of intraperitoneal ciprofloxacin in patients on CAPD.J Antimicrob Chemother1989; 23: 253–9.
